The global neurodegenerative diseases drugs market size growth is expected to derive growth from the rising prevalence of neurodegenerative diseases especially among the aging population. Fortune Business Insights in a report, titled “Neurodegenerative Diseases Drugs: Global Market Analysis, Insights and Forecast, 2019-2026” offers valuable insights into the trends prevailing in the market. In 2018, the global market was valued at US$35,497.3 Mn and is projected to be worth US$ 62,786.2 Mn by 2026. At this pace, the global market is estimated to exhibit a healthy CAGR of 7.2% during the forecast duration.
The report provides market analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product & service launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/neurodegenerative-diseases-drugs-market-100661
North America Dominates with Rising R&D Investments
In 2018, the North America market was valued at US$ 18,174.6 Mn and is anticipated to maintain its dominance throughout the forecast years. Neurodegenerative diseases have become more prevalent in the U.S. owing to an increasingly aging population. As per the Alzheimer’s Association, around 5.4 million Americans were suffering from Alzheimer’s in the year 2016. Moreover, this disease is more prevalent among people aged 65 years and above. As per research studies, approximately 30,000 people in the U.S. are projected to be suffering from another neurodegenerative disease called Huntington’s disease. As per a study conducted by the Parkinson’s Association in 2018, around 1.2 million people in the U.S are estimated to be suffering from Parkinson’s disease by 2030. With the continuous rise in population, this disease is projected to double between 2018 and 2026. Considering these numbers, the market is likely to grow in North America. This, coupled with favorable healthcare reimbursement policies and rising research and development (R&D) investments is driving the market in this region.
The market in Asia Pacific is anticipated to report a considerable CAGR primarily on account of rising geriatric population.
Key Companies and Manufacturers Covered:
- Biogen
- Pfizer, Inc.
- Hoffmann-La Roche Ltd
- Merck & Co., Inc.
- Novartis AG
- Sanofi
- Teva Pharmaceutical Industries Ltd.
- Orion Pharma
- UCB S.A
- ACADIA Pharmaceuticals Inc.
- Lundbeck A/S
- Mitsubishi Tanabe Pharma Corporation
Out research methodology is robust and includes data triangulation based on bottom-up and top-down approaches. We validated the approximate market number with the help of primary research. Secondary research was conducted to find out detailed information about mergers & acquisitions, collaborations, joint ventures, and agreements. At the same time, we have derived significant information about the market dynamics associated with growth drivers, trends, and obstacles.
Key questions answered in the report:
What will the market growth rate of Neurodegenerative Diseases Drugs Market in 2026?
What are the key factors driving the global Neurodegenerative Diseases Drugs Market?
Who are the key manufacturers in Neurodegenerative Diseases Drugs Market space?
What are the market opportunities, market risk and market overview of the Neurodegenerative Diseases Drugs Market?
What are sales, revenue, and price analysis of top manufacturers of Neurodegenerative Diseases Drugs Market?
Who are the distributors, traders and dealers of Neurodegenerative Diseases Drugs Market?
What are the Neurodegenerative Diseases Drugs Market opportunities and threats faced by the vendors in the global Robotic Surgical Procedures industry?
What are sales, revenue, and price analysis by types and applications of Neurodegenerative Diseases Drugs Market?
What are sales, revenue, and price analysis by regions of Robotic Surgical Procedures industry?
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.
Click here to get the short-term and long-term impact of COVID-19 on this Neurodegenerative Diseases Drugs Market.
Please visit: https://www.fortunebusinessinsights.com/industry-reports/neurodegenerative-diseases-drugs-market-100661
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic. We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.
Key Features of Neurodegenerative Diseases Drugs Market Report:
- Overview, Industry Life Cycle Analysis, Supply Chain Analysis
- Size, Trends, Growth Drivers, Constraints, SWOT Analysis, Forecast Analysis
- Competitive Landscapes: Market Share, Product Portfolio, New Product Launches, etc.
- Market attractiveness and Associated Growth Opportunities
- Strategic Growth Opportunities for the Existing and New Players
- Key Success Factors
Biogen’s Strategic Initiatives Helps the Company to Earn More Profits
In the year 2018, Biogen was dominating the global market. Neurodegenerative disease drug discovery and some important strategic decisions help the company to gain more attention. The launch of a drug called SPINRAZA and increasing sales of another drug called Tecfidera in 2018 helped the company to strengthen its product portfolio. Also, the company entered into a strategic partnership with F. Hoffmann-La Roche Ltd. to ensure robust distribution of drugs. This, together with the launch of two new drugs called Madopar and Ocrevus helped F. Hoffmann-La Roche Ltd. to gain the second position in the market.
Have Any Query? Ask Our Experts:https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/neurodegenerative-diseases-drugs-market-100661
Table of Content:
1 Neurodegenerative Diseases Drugs Market Overview
1.1 Neurodegenerative Diseases Drugs Product Overview
1.2 Neurodegenerative Diseases Drugs Market Segment by Type
1.3 Global Neurodegenerative Diseases Drugs Market Size by Type (2015-2027)
1.3.1 Global Neurodegenerative Diseases Drugs Market Size Overview by Type (2015-2027)
1.3.2 Global Neurodegenerative Diseases Drugs Historic Market Size Review by Type (2015-2021)
1.3.2.1 Global Neurodegenerative Diseases Drugs Sales Market Share Breakdown by Type (2015-2027)
1.3.2.2 Global Neurodegenerative Diseases Drugs Market Share Breakdown by Type (2015-2027)
1.3.2.3 Global Neurodegenerative Diseases Drugs Average Selling Price (ASP) by Type (2015-2027)
1.3.3 Global Neurodegenerative Diseases Drugs Market Size Forecast by Type (2021-2027)
1.3.3.1 Global Neurodegenerative Diseases Drugs Sales Market Share Breakdown by Application (2021-2027)
1.3.3.2 Global Neurodegenerative Diseases Drugs Revenue Market Share Breakdown by Application (2021-2027)
1.3.3.3 Global Neurodegenerative Diseases Drugs Average Selling Price (ASP) by Application (2021-2027)
1.4 Key Regions Market Size Segment by Type (2015-2021)
1.4.1 North America Neurodegenerative Diseases Drugs Sales Breakdown by Type (2015-2027)
1.4.2 Europe Neurodegenerative Diseases Drugs Sales Breakdown by Type (2015-2027)
1.4.3 Asia-Pacific Neurodegenerative Diseases Drugs Sales Breakdown by Type (2015-2027)
1.4.4 Latin America Neurodegenerative Diseases Drugs Sales Breakdown by Type (2015-2027)
1.4.5 Middle East and Africa Neurodegenerative Diseases Drugs Sales Breakdown by Type (2015-2027)
2 Global Neurodegenerative Diseases Drugs Market Competition by Company
2.1 Global Top Players by Neurodegenerative Diseases Drugs Sales (2015-2021)
2.2 Global Top Players by Neurodegenerative Diseases Drugs Revenue (2015-2021)
2.3 Global Top Players Neurodegenerative Diseases Drugs Average Selling Price (ASP) (2015-2021)
2.4 Global Top Company Neurodegenerative Diseases Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Neurodegenerative Diseases Drugs Market Competitive Situation and Trends
2.5.1 Neurodegenerative Diseases Drugs Market Growth Rate (2015-2021)
2.5.2 Global 5 and 10 Largest Company by Neurodegenerative Diseases Drugs Sales and Revenue in 2019
2.6 Global Top Company by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neurodegenerative Diseases Drugs as of 2019)
2.7 Date of Key Company Enter into Neurodegenerative Diseases Drugs Market
2.8 Key Company Neurodegenerative Diseases Drugs Product Offered
2.9 Mergers and Acquisitions, Expansion
3 Global Neurodegenerative Diseases Drugs Status and Outlook by Region (2015-2027)
3.1 Global Neurodegenerative Diseases Drugs Market Size and CAGR by Region: 2015 VS 2021 VS 2027
3.2 Global Neurodegenerative Diseases Drugs Market Size Market Share by Region (2015-2021)
3.2.1 Global Neurodegenerative Diseases Drugs Sales Market Share by Region (2015-2021)
3.2.2 Global Neurodegenerative Diseases Drugs Revenue Market Share by Region (2015-2021)
3.2.3 Global Neurodegenerative Diseases Drugs Sales, Revenue, Price and Gross Margin (2015-2021)
3.3 Global Neurodegenerative Diseases Drugs Market Size Market Share by Region (2021-2027)
3.3.1 Global Neurodegenerative Diseases Drugs Sales Market Share by Region (2021-2027)
3.3.2 Global Neurodegenerative Diseases Drugs Revenue Market Share by Region (2021-2027)
3.3.3 Global Neurodegenerative Diseases Drugs Sales, Revenue, Price and Gross Margin (2021-2027)
3.4 North America Neurodegenerative Diseases Drugs Market Size By Growth (2015-2027)
3.4.1 North America Neurodegenerative Diseases Drugs Revenue By Growth (2015-2027)
3.4.2 North America Neurodegenerative Diseases Drugs Sales By Growth (2015-2027)
3.5 Asia-Pacific Neurodegenerative Diseases Drugs Market Size By Growth (2015-2027)
3.5.1 Asia-Pacific Neurodegenerative Diseases Drugs Revenue By Growth (2015-2027)
3.5.2 Asia-Pacific Neurodegenerative Diseases Drugs Sales By Growth (2015-2027)
3.6 Europe Neurodegenerative Diseases Drugs Market Size By Growth (2015-2027)
3.6.1 Europe Neurodegenerative Diseases Drugs Revenue By Growth (2015-2027)
3.6.2 Europe Neurodegenerative Diseases Drugs Sales By Growth (2015-2027)
3.7 Latin America Neurodegenerative Diseases Drugs Market Size By Growth (2015-2027)
3.7.1 Latin America Neurodegenerative Diseases Drugs Revenue By Growth (2015-2027)
3.7.2 Latin America Neurodegenerative Diseases Drugs Sales By Growth (2015-2027)
3.8 Middle East and Africa Neurodegenerative Diseases Drugs Market Size By Growth (2015-2027)
3.8.1 Middle East and Africa Neurodegenerative Diseases Drugs Revenue By Growth (2015-2027)
3.8.2 Middle East and Africa Neurodegenerative Diseases Drugs Sales By Growth (2015-2027)
4 Global Neurodegenerative Diseases Drugs by Application
4.1 Neurodegenerative Diseases Drugs Segment by Application
4.1.1 Residential
4.1.2 Commercial
4.2 Global Neurodegenerative Diseases Drugs Sales by Application: 2015 VS 2021 VS 2027
4.3 Global Neurodegenerative Diseases Drugs Historic Sales by Application (2015-2021)
4.4 Global Neurodegenerative Diseases Drugs Forecasted Sales by Application (2021-2027)
4.5 Key Regions Neurodegenerative Diseases Drugs Market Size by Application
4.5.1 North America Neurodegenerative Diseases Drugs by Application
4.5.2 Europe Neurodegenerative Diseases Drugs by Application
4.5.3 Asia-Pacific Neurodegenerative Diseases Drugs by Application
4.5.4 Latin America Neurodegenerative Diseases Drugs by Application
4.5.5 Middle East and Africa Neurodegenerative Diseases Drugs by Application
5 North America Neurodegenerative Diseases Drugs Market Size by Country (2015-2027)
5.1 North America Market Size Market Share by Country (2015-2021)
5.1.1 North America Neurodegenerative Diseases Drugs Sales Market Share by Country (2015-2021)
5.1.2 North America Neurodegenerative Diseases Drugs Revenue Market Share by Country (2015-2021)
5.2 North America Market Size Market Share by Country (2021-2027)
5.2.1 North America Neurodegenerative Diseases Drugs Sales Market Share by Country (2021-2027)
5.2.2 North America Neurodegenerative Diseases Drugs Revenue Market Share by Country (2021-2027)
5.3 North America Market Size By Growth by Country
5.3.1 U.S. Neurodegenerative Diseases Drugs Market Size By Growth (2015-2027)
5.3.2 Canada Neurodegenerative Diseases Drugs Market Size By Growth (2015-2027)
6 Europe Neurodegenerative Diseases Drugs Market Size by Country (2015-2027)
6.1 Europe Market Size Market Share by Country (2015-2021)
6.1.1 Europe Neurodegenerative Diseases Drugs Sales Market Share by Country (2015-2021)
6.1.2 Europe Neurodegenerative Diseases Drugs Revenue Market Share by Country (2015-2021)
6.2 Europe Market Size Market Share by Country (2021-2027)
6.2.1 Europe Neurodegenerative Diseases Drugs Sales Market Share by Country (2021-2027)
6.2.2 Europe Neurodegenerative Diseases Drugs Revenue Market Share by Country (2021-2027)
6.3 Europe Market Size By Growth by Country
6.3.1 Germany Neurodegenerative Diseases Drugs Market Size By Growth (2015-2027)
6.3.2 France Neurodegenerative Diseases Drugs Market Size By Growth (2015-2027)
6.3.3 U.K. Neurodegenerative Diseases Drugs Market Size By Growth (2015-2027)
6.3.4 Italy Neurodegenerative Diseases Drugs Market Size By Growth (2015-2027)
6.3.5 Russia Neurodegenerative Diseases Drugs Market Size By Growth (2015-2027)
7 Asia-Pacific Neurodegenerative Diseases Drugs Market Size by Country (2015-2027)
7.1 Asia-Pacific Market Size Market Share by Country (2015-2021)
7.1.1 Asia-Pacific Neurodegenerative Diseases Drugs Sales Market Share by Country (2015-2021)
7.1.2 Asia-Pacific Neurodegenerative Diseases Drugs Revenue Market Share by Country (2015-2021)
7.2 Asia-Pacific Market Size Market Share by Country (2021-2027)
7.2.1 Asia-Pacific Neurodegenerative Diseases Drugs Sales Market Share by Country (2021-2027)
7.2.2 Asia-Pacific Neurodegenerative Diseases Drugs Revenue Market Share by Country (2021-2027)
7.3 Asia-Pacific Market Size By Growth by Country
7.3.1 China Neurodegenerative Diseases Drugs Market Size By Growth (2015-2027)
7.3.2 Japan Neurodegenerative Diseases Drugs Market Size By Growth (2015-2027)
7.3.3 South Korea Neurodegenerative Diseases Drugs Market Size By Growth (2015-2027)
7.3.4 India Neurodegenerative Diseases Drugs Market Size By Growth (2015-2027)
7.3.5 Australia Neurodegenerative Diseases Drugs Market Size By Growth (2015-2027)
7.3.6 Taiwan Neurodegenerative Diseases Drugs Market Size By Growth (2015-2027)
7.3.7 Indonesia Neurodegenerative Diseases Drugs Market Size By Growth (2015-2027)
7.3.8 Thailand Neurodegenerative Diseases Drugs Market Size By Growth (2015-2027)
7.3.9 Malaysia Neurodegenerative Diseases Drugs Market Size By Growth (2015-2027)
7.3.10 Philippines Neurodegenerative Diseases Drugs Market Size By Growth (2015-2027)
Continue…
Reasons to Purchase this Report:
- Detailed business profiles including product offerings, recent developments, key financial information, and strategies employed by main market players.
- Analysis of various regions and countries that includes the demand and supply based actions, which consequently have a major influence on the market’s expansion.
- Market dynamics and opportunities for growth for players in the near future.
- Competitive landscape describing the market revenue shares of key players.
- Market segmentation analysis that deals with quantitative and qualitative research, discussing the influence of policy-based and economical aspects.
Our proven methodologies and systematic analysis help in making confident business and strategic decisions.
A market study that conducts at Fortune Business Insights can save significant cost and time, and can help prevent making costly mistakes.
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245